ASO-210-loaded UCMSC-exosomes reduced psoriasis symptoms, exhausted Th17 cells and reduced enrichment of proinflammatory cytokines, such as IL-17A, IFN-γ, IL-6 and TNF-α, in both spleen and skin lesions in vivo. Here, TNF is linked to psoriasis.